AUTHOREA
Log in
Sign Up
Browse Preprints
LOG IN
SIGN UP
Ryo Akazawa
Public Documents
1
March 30, 2022
Inotuzumab ozogamicin is an effective treatment for CD22-positive acute undifferentia...
Ryo Akazawa, Itaru Kato, Hirohito Kubota, et al.